• DOI:10.1097/CHI.0B013E31802F5F03
Corpus ID: 9187105

Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials.

@article{Emslie2007VenlafaxineEF,
  title={Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials.},
  author={G. Emslie and R. Findling and P. Yeung and N. R. Kunz and Y. Li},
  journal={Journal of the American Academy of Child and Adolescent Psychiatry},
  year={2007},
  volume={46 4},
  pages={
          479-88
        }
}

G. Emslie, R. Findling, +2 authors Y. Li

Published 2007

Medicine

Journal of the American Academy of Child and Adolescent Psychiatry

OBJECTIVE The safety, efficacy, and tolerability of venlafaxine extended release (ER) in subjects ages 7 to 17 years with major depressive disorder were evaluated in two multicenter, randomized, double-blind, placebo-controlled trials conducted between October 1997 and August 2001. METHOD Participants received venlafaxine ER (flexible dose, based on body weight; intent to treat, n = 169) or placebo (intent to treat, n = 165) for up to 8 weeks. The primary efficacy variable was the change from… CONTINUE READING

View on PubMed

doi.org

Save to Library

Create Alert

Cite

Launch Research Feed